Revised SPC: Lyumjev (insulin lispro) 100 units/mL solution for injection- all presentations
Data added from PRONTO-T1D and PRONTO-T2D (multiple-dose injection administration) studies noting injection site reactions occurred in 2.7 % of patients treated with Lyumjev, and from PRONTO-Pump-2 study, noting infusion site reactions reported in 38 % of patients on Lyumjev.
Source:
electronic Medicines compendium